Eli Lilly and Company Price Today
Eli Lilly and Company
LLY
Healthcare
$426.69B
💰
Market Cap
71.3
💸
Price to Earnings
$6.3
🎉
EPS
+68
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
9 |
Hold |
7 |
Sell |
1 |
Strong Sell |
0 |
LLY Price Forecast Target
449.5 👉 492.9 +10%
LLY EPS Forecast
6.3 👉 10.7 +70%
Financials
Profit Margin
21 %
Revenue Growth
-10.9 %
Dividend
$ 4.52
Held Percent
0.2% - Insiders
84.0% - Institutions
15.8% - Public
Major Fund Holders
-
💰 Lilly Endowment, Inc $45.4B
-
💰 Vanguard Group Inc $31.5B
-
💰 Blackrock Inc. $29.5B
-
💰 PNC Financial Services Group, Inc. $23.3B
-
💰 State Street Corporation $14.9B
Stock Ideas
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…📮FAQ
Some Frequently Asked Questions.
The Eli Lilly and Company industry is Drug Manufacturers—General
The Eli Lilly and Company sector is Healthcare
The Eli Lilly and Company forecasted predicted Price to Earnings PE ratio is 42.0
The Eli Lilly and Company Price to Earnings PE ratio is 71.3
The Market Capitalization of Eli Lilly and Company is $426.69B
There are total of 947393373 float shares with 84.0% held by Institutions and 0.2% held by insiders
The MEli Lilly and Company forecasted Earnings per Share EPS is $10.7
The Eli Lilly and Company Earnings per Share EPS is 6.3
The Eli Lilly and Company company has $21911600000 gross profits with 21 profit margins
The Eli Lilly and Company Earnings Growth is -0.29% with -0.293% quarterly earnings growth
The Eli Lilly and Company Revenue is $27691399168 with -0.109 revenue growth
The price target for Eli Lilly and Company stock is $492.9 for the high target and $261.7 for the low target
The consensus analyst recommendations for Eli Lilly and Company is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Eli Lilly and Company is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 9
- Hold: 7
- Sell: 1
- Strong Sell: 0
The Beta of Eli Lilly and Company is 0.3
The dividend of Eli Lilly and Company is $4.52
The dividend yield of Eli Lilly and Company is 0.0101%
The biggest institutional and mutual fund holders of Eli Lilly and Company stock are
- Lilly Endowment, Inc
- Vanguard Group Inc
- Blackrock Inc.
- PNC Financial Services Group, Inc.
The Eli Lilly and Company ESG Score is 68, with the following breakdown:
- E: 3.43
- S: 17.4
- G: 11.56